HRD1-mediated ERAD capacity for proinsulin might be exceeded in early type 2 diabetes when β cell proinsulin levels — and misfolded proinsulin levels — are unusually elevated, such as has been observed in the islets of young db/db mice (43, 49). This evidence concerns the gene INS and type 2 diabetes mellitus.